Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma.

Webster MR, Fane ME, Alicea GM, Basu S, Kossenkov AV, Marino GE, Douglass SM, Kaur A, Ecker BL, Gnanapradeepan K, Ndoye A, Kugel C, Valiga A, Palmer J, Liu Q, Xu X, Morris J, Yin X, Wu H, Xu W, Zheng C, Karakousis GC, Amaravadi RK, Mitchell TC, Almeida FV, Xiao M, Rebecca VW, Wang YJ, Schuchter LM, Herlyn M, Murphy ME, Weeraratna AT.

Mol Cell. 2019 Dec 11. pii: S1097-2765(19)30838-X. doi: 10.1016/j.molcel.2019.11.009. [Epub ahead of print]

PMID:
31836388
2.

Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of Hyperbilirubinemia.

Chen B, Trudeau MT, Maggino L, Ecker BL, Keele LJ, DeMatteo RP, Drebin JA, Fraker DL, Lee MK 4th, Roses RE, Vollmer CM Jr.

Ann Surg Oncol. 2019 Nov 5. doi: 10.1245/s10434-019-08044-w. [Epub ahead of print]

PMID:
31691110
3.

Pancreatic Head Resection Following Roux-en-Y Gastric Bypass: Operative Considerations and Outcomes.

Trudeau MT, Maggino L, Ecker BL, Vollmer CM; Pancreatic Head Resection after Roux-en-Y Gastric Bypass Study Group.

J Gastrointest Surg. 2019 Sep 4. doi: 10.1007/s11605-019-04366-y. [Epub ahead of print]

PMID:
31485901
4.

The impact of surgery for metastatic pancreatic neuroendocrine tumor: a contemporary evaluation matching for chromogranin a level.

Concors SJ, Sinnamon AJ, Ecker BL, Metz DC, Vollmer CM, Fraker DL, Roses RE.

HPB (Oxford). 2019 Jun 22. pii: S1365-182X(19)30561-1. doi: 10.1016/j.hpb.2019.05.011. [Epub ahead of print]

PMID:
31239188
5.

Trends in practice patterns and outcomes: A decade of sarcoma care in the United States.

Song Y, Ecker BL, Tang R, Maggino L, Roses RE, DeMatteo RP, Fraker DL, Karakousis GC.

Surg Oncol. 2019 Jun;29:168-177. doi: 10.1016/j.suronc.2019.05.018. Epub 2019 May 21.

PMID:
31196484
6.

Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.

Ecker BL, Vollmer CM Jr, Behrman SW, Allegrini V, Aversa J, Ball CG, Barrows CE, Berger AC, Cagigas MN, Christein JD, Dixon E, Fisher WE, Freedman-Weiss M, Guzman-Pruneda F, Hollis RH, House MG, Kent TS, Kowalsky SJ, Malleo G, Salem RR, Salvia R, Schmidt CR, Seykora TF, Zheng R, Zureikat AH, Dickson PV.

JAMA Surg. 2019 May 29. doi: 10.1001/jamasurg.2019.1170. [Epub ahead of print]

PMID:
31141112
7.

Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal.

Maggino L, Malleo G, Bassi C, Allegrini V, McMillan MT, Borin A, Chen B, Drebin JA, Ecker BL, Fraker DL, Lee MK, Paiella S, Roses RE, Salvia R, Vollmer CM Jr.

Ann Surg. 2019 Jun;269(6):1146-1153. doi: 10.1097/SLA.0000000000002673.

PMID:
31082914
8.

Impact of obesity on breast cancer recurrence and minimal residual disease.

Ecker BL, Lee JY, Sterner CJ, Solomon AC, Pant DK, Shen F, Peraza J, Vaught L, Mahendra S, Belka GK, Pan TC, Schmitz KH, Chodosh LA.

Breast Cancer Res. 2019 Mar 13;21(1):41. doi: 10.1186/s13058-018-1087-7.

9.

Author Correction: Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis.

Liu S, Zhang G, Guo J, Chen X, Lei J, Ze K, Dong L, Dai X, Gao Y, Song D, Ecker BL, Yang R, Feltcher C, Peng K, Feng C, Chen H, Lee RX, Kerestes H, Niu J, Kumar S, Xu W, Zhang J, Wei Z, Martin JS, Liu X, Mills G, Lu Y, Guo W, Sun L, Zhang L, Weeraratna A, Herlyn M, Wei W, Lee FS, Xu X.

Nat Commun. 2019 Mar 11;10(1):1211. doi: 10.1038/s41467-019-09195-w.

10.

Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis.

Liu S, Zhang G, Guo J, Chen X, Lei J, Ze K, Dong L, Dai X, Gao Y, Song D, Ecker BL, Yang R, Feltcher C, Peng K, Feng C, Chen H, Lee RX, Kerestes H, Niu J, Kumar S, Xu W, Zhang J, Wei Z, Martin JS, Liu X, Mills G, Lu Y, Guo W, Sun L, Zhang L, Weeraratna A, Herlyn M, Wei W, Lee FS, Xu X.

Nat Commun. 2018 Dec 21;9(1):5426. doi: 10.1038/s41467-018-07126-9. Erratum in: Nat Commun. 2019 Mar 11;10(1):1211.

11.

Response to Comment on "Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy: Response to Goussous and Cunningham".

Ecker BL, Vollmer CM Jr.

Ann Surg. 2019 Aug;270(2):e58-e59. doi: 10.1097/SLA.0000000000003121. No abstract available.

PMID:
30499813
12.

Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility.

Kaur A, Ecker BL, Douglass SM, Kugel CH 3rd, Webster MR, Almeida FV, Somasundaram R, Hayden J, Ban E, Ahmadzadeh H, Franco-Barraza J, Shah N, Mellis IA, Keeney F, Kossenkov A, Tang HY, Yin X, Liu Q, Xu X, Fane M, Brafford P, Herlyn M, Speicher DW, Wargo JA, Tetzlaff MT, Haydu LE, Raj A, Shenoy V, Cukierman E, Weeraratna AT.

Cancer Discov. 2019 Jan;9(1):64-81. doi: 10.1158/2159-8290.CD-18-0193. Epub 2018 Oct 2.

13.

Age-Related Changes in HAPLN1 Increase Lymphatic Permeability and Affect Routes of Melanoma Metastasis.

Ecker BL, Kaur A, Douglass SM, Webster MR, Almeida FV, Marino GE, Sinnamon AJ, Neuwirth MG, Alicea GM, Ndoye A, Fane M, Xu X, Sim MS, Deutsch GB, Faries MB, Karakousis GC, Weeraratna AT.

Cancer Discov. 2019 Jan;9(1):82-95. doi: 10.1158/2159-8290.CD-18-0168. Epub 2018 Oct 2.

14.

Taking Theory to Practice: Quality Improvement for Pancreaticoduodenectomy and Development and Integration of the Fistula Risk Score.

Ecker BL, McMillan MT, Maggino L, Vollmer CM Jr.

J Am Coll Surg. 2018 Oct;227(4):430-438.e1. doi: 10.1016/j.jamcollsurg.2018.06.009. Epub 2018 Jul 5.

PMID:
29981917
15.

Response to: Managing the High-risk Pancreatic Anastomosis.

Ecker BL, Maggino L, Vollmer CM Jr.

Ann Surg. 2019 Jan;269(1):e8-e9. doi: 10.1097/SLA.0000000000002883. No abstract available.

PMID:
29923879
16.

Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations.

Kugel CH 3rd, Douglass SM, Webster MR, Kaur A, Liu Q, Yin X, Weiss SA, Darvishian F, Al-Rohil RN, Ndoye A, Behera R, Alicea GM, Ecker BL, Fane M, Allegrezza MJ, Svoronos N, Kumar V, Wang DY, Somasundaram R, Hu-Lieskovan S, Ozgun A, Herlyn M, Conejo-Garcia JR, Gabrilovich D, Stone EL, Nowicki TS, Sosman J, Rai R, Carlino MS, Long GV, Marais R, Ribas A, Eroglu Z, Davies MA, Schilling B, Schadendorf D, Xu W, Amaravadi RK, Menzies AM, McQuade JL, Johnson DB, Osman I, Weeraratna AT.

Clin Cancer Res. 2018 Nov 1;24(21):5347-5356. doi: 10.1158/1078-0432.CCR-18-1116. Epub 2018 Jun 13.

17.

Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR.

Walton ZE, Patel CH, Brooks RC, Yu Y, Ibrahim-Hashim A, Riddle M, Porcu A, Jiang T, Ecker BL, Tameire F, Koumenis C, Weeraratna AT, Welsh DK, Gillies R, Alwine JC, Zhang L, Powell JD, Dang CV.

Cell. 2018 Jun 28;174(1):72-87.e32. doi: 10.1016/j.cell.2018.05.009. Epub 2018 May 31.

18.

The Beneficial Effects of Minimizing Blood Loss in Pancreatoduodenectomy.

Seykora TF, Ecker BL, McMillan MT, Maggino L, Beane JD, Fong ZV, Hollis RH, Jamieson NB, Javed AA, Kowalsky SJ, Kunstman JW, Malleo G, Poruk KE, Soares K, Valero V 3rd, Velu LKP, Watkins AA, Vollmer CM Jr; Pancreas Fistula Study Group.

Ann Surg. 2019 Jul;270(1):147-157. doi: 10.1097/SLA.0000000000002714.

PMID:
29489483
19.

Impact of Operative Time on Outcomes after Pancreatic Resection: A Risk-Adjusted Analysis Using the American College of Surgeons NSQIP Database.

Maggino L, Liu JB, Ecker BL, Pitt HA, Vollmer CM Jr.

J Am Coll Surg. 2018 May;226(5):844-857.e3. doi: 10.1016/j.jamcollsurg.2018.01.004. Epub 2018 Mar 1.

PMID:
29408353
20.

Patterns of Discordance Between Pretransplant Imaging Stage of Hepatocellular Carcinoma and Posttransplant Pathologic Stage: A Contemporary Appraisal of the Milan Criteria.

Ecker BL, Hoteit MA, Forde KA, Hsu CC, Reddy KR, Furth EE, Siegelman ES, Habibollahi P, Ben-Josef E, Porrett PM, Abt PL, Shaked A, Olthoff KM, Levine MH.

Transplantation. 2018 Apr;102(4):648-655. doi: 10.1097/TP.0000000000002056.

PMID:
29319629
21.

Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External Validation.

Mungroop TH, van Rijssen LB, van Klaveren D, Smits FJ, van Woerden V, Linnemann RJ, de Pastena M, Klompmaker S, Marchegiani G, Ecker BL, van Dieren S, Bonsing B, Busch OR, van Dam RM, Erdmann J, van Eijck CH, Gerhards MF, van Goor H, van der Harst E, de Hingh IH, de Jong KP, Kazemier G, Luyer M, Shamali A, Barbaro S, Armstrong T, Takhar A, Hamady Z, Klaase J, Lips DJ, Molenaar IQ, Nieuwenhuijs VB, Rupert C, van Santvoort HC, Scheepers JJ, van der Schelling GP, Bassi C, Vollmer CM, Steyerberg EW, Abu Hilal M, Groot Koerkamp B, Besselink MG; Dutch Pancreatic Cancer Group.

Ann Surg. 2019 May;269(5):937-943. doi: 10.1097/SLA.0000000000002620.

PMID:
29240007
22.

Combination of Neoadjuvant Transcatheter Arterial Chemoembolization and Orthotopic Liver Transplantation for the Treatment of Cirrhotomimetic Hepatocellular Carcinoma.

Habibollahi P, Shamchi SP, Tondon R, Ecker BL, Gade TP, Hunt S, Soulen MC, Furth EE, Levine MH, Nadolski G.

J Vasc Interv Radiol. 2018 Feb;29(2):237-243. doi: 10.1016/j.jvir.2017.09.008. Epub 2017 Dec 6.

PMID:
29221923
23.

Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.

Ecker BL, Vining CC, Roses RE, Maggino L, Lee MK, Drebin JA, Fraker DL, Vollmer CM Jr, Datta J.

Ann Surg Oncol. 2017 Dec;24(13):3926-3933. doi: 10.1245/s10434-017-6095-9. Epub 2017 Sep 26.

PMID:
28952140
24.

Identification of an Optimal Cut-off for Drain Fluid Amylase on Postoperative Day 1 for Predicting Clinically Relevant Fistula After Distal Pancreatectomy: A Multi-institutional Analysis and External Validation.

Maggino L, Malleo G, Bassi C, Allegrini V, Beane JD, Beckman RM, Chen B, Dickson EJ, Drebin JA, Ecker BL, Fraker DL, House MG, Jamieson NB, Javed AA, Kowalsky SJ, Lee MK, McMillan MT, Roses RE, Salvia R, Valero V 3rd, Velu LKP, Wolfgang CL, Zureikat AH, Vollmer CM Jr.

Ann Surg. 2019 Feb;269(2):337-343. doi: 10.1097/SLA.0000000000002532.

PMID:
28938266
25.

Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group.

Ecker BL, McMillan MT, Allegrini V, Bassi C, Beane JD, Beckman RM, Behrman SW, Dickson EJ, Callery MP, Christein JD, Drebin JA, Hollis RH, House MG, Jamieson NB, Javed AA, Kent TS, Kluger MD, Kowalsky SJ, Maggino L, Malleo G, Valero V 3rd, Velu LKP, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM Jr.

Ann Surg. 2019 Jan;269(1):143-149. doi: 10.1097/SLA.0000000000002491.

PMID:
28857813
26.

Donation after cardiac death in the hepatocellular carcinoma patient: Same indication?

Vining CC, Ecker BL, Abt PL, Olthoff KM.

Liver Transpl. 2017 Oct;23(S1):S27-S33. doi: 10.1002/lt.24862. No abstract available.

27.

Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies.

Ecker BL, McMillan MT, Maggino L, Allegrini V, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Bloomston M, Callery MP, Christein JD, Dickson E, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, Hollis RH, House MG, Hughes SJ, Jamieson NB, Kent TS, Kowalsky SJ, Kunstman JW, Malleo G, Salem RR, Soares KC, Valero V 3rd, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM Jr.

J Gastrointest Surg. 2018 Jan;22(1):68-76. doi: 10.1007/s11605-017-3547-2. Epub 2017 Aug 24. No abstract available.

PMID:
28840459
28.

Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy.

Ecker BL, McMillan MT, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Dickson EJ, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, Hollis RH, House MG, Hughes SJ, Jamieson NB, Javed AA, Kent TS, Kowalsky SJ, Kunstman JW, Malleo G, Poruk KE, Salem RR, Schmidt CR, Soares K, Stauffer JA, Valero V, Velu LKP, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM Jr.

Ann Surg. 2018 Apr;267(4):608-616. doi: 10.1097/SLA.0000000000002327.

PMID:
28594741
29.

Adjuvant chemotherapy in resectable synovial sarcoma.

Vining CC, Sinnamon AJ, Ecker BL, Kelz RR, Fraker DL, Roses RE, Karakousis GC.

J Surg Oncol. 2017 Sep;116(4):550-558. doi: 10.1002/jso.24688. Epub 2017 Jun 5.

PMID:
28580620
30.

Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature.

Datta J, Ecker BL, Neuwirth MG, Geha RC, Fraker DL, Roses RE, Karakousis GC.

Surg Oncol. 2017 Jun;26(2):117-124. doi: 10.1016/j.suronc.2017.01.008. Epub 2017 Feb 2. Review.

PMID:
28577717
31.

In Response to "Impact of Neoadjuvant Chemoradiation on Lymph Node Status in Esophageal Cancer".

Ecker BL, Dempsey DT.

Ann Surg. 2017 May;265(5):e69. doi: 10.1097/SLA.0000000000001262. No abstract available.

PMID:
28394793
32.

Response to: "Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation".

McMillan MT, Maggino L, Ecker BL, Vollmer CM Jr.

Ann Surg. 2018 Jul;268(1):e6-e7. doi: 10.1097/SLA.0000000000002218. No abstract available.

PMID:
28296660
33.

Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.

Ecker BL, McMillan MT, Datta J, Lee MK, Karakousis GC, Vollmer CM Jr, Drebin JA, Fraker DL, Roses RE.

Cancer. 2017 May 15;123(6):967-976. doi: 10.1002/cncr.30439. Epub 2016 Nov 7.

34.

Pancreatic fistula risk for pancreatoduodenectomy: an international survey of surgeon perception.

McMillan MT, Malleo G, Bassi C, Sprys MH, Ecker BL, Drebin JA, Vollmer CM Jr.

HPB (Oxford). 2017 Jun;19(6):515-524. doi: 10.1016/j.hpb.2017.01.022. Epub 2017 Feb 12.

35.

Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study.

Ecker BL, McMillan MT, Datta J, Dempsey DT, Karakousis GC, Fraker DL, Drebin JA, Mamtani R, Giantonio BJ, Roses RE.

Eur J Cancer. 2016 Dec;69:135-141. doi: 10.1016/j.ejca.2016.09.027. Epub 2016 Nov 4.

PMID:
27821316
36.

Implications of Lymph Node Evaluation in the Management of Resectable Soft Tissue Sarcoma.

Ecker BL, Peters MG, McMillan MT, Sinnamon AJ, Zhang PJ, Kelz RR, Roses RE, Drebin JA, Fraker DL, Karakousis GC.

Ann Surg Oncol. 2017 Feb;24(2):425-433. doi: 10.1245/s10434-016-5641-1. Epub 2016 Oct 26.

PMID:
27785659
37.

A prognostic model for resectable soft tissue and cutaneous angiosarcoma.

Sinnamon AJ, Neuwirth MG, McMillan MT, Ecker BL, Bartlett EK, Zhang PJ, Kelz RR, Fraker DL, Roses RE, Karakousis GC.

J Surg Oncol. 2016 Oct;114(5):557-563. doi: 10.1002/jso.24352. Epub 2016 Jul 4.

PMID:
27378102
38.

Externalized Stents for Pancreatoduodenectomy Provide Value Only in High-Risk Scenarios.

McMillan MT, Ecker BL, Behrman SW, Callery MP, Christein JD, Drebin JA, Fraker DL, Kent TS, Lee MK, Roses RE, Sprys MH, Vollmer CM Jr.

J Gastrointest Surg. 2016 Dec;20(12):2052-2062. Epub 2016 Oct 11.

PMID:
27730401
39.

Preoperative radiotherapy in the management of retroperitoneal liposarcoma.

Ecker BL, Peters MG, McMillan MT, Sinnamon AJ, Zhang PJ, Fraker DL, Levin WP, Roses RE, Karakousis GC.

Br J Surg. 2016 Dec;103(13):1839-1846. doi: 10.1002/bjs.10305. Epub 2016 Sep 29.

PMID:
27682864
40.

HER3 Expression Is a Marker of Tumor Progression in Premalignant Lesions of the Gastroesophageal Junction.

Ecker BL, Taylor L, Zhang PJ, Furth EE, Ginsberg GG, McMillan MT, Datta J, Czerniecki BJ, Roses RE.

PLoS One. 2016 Aug 25;11(8):e0161781. doi: 10.1371/journal.pone.0161781. eCollection 2016.

41.

Response to "Minimally invasive gastrectomy for gastric adenocarcinoma in the United States: Utilization and short-term oncologic outcomes".

Ecker BL, Roses RE.

J Surg Oncol. 2016 Jun;113(7):846. doi: 10.1002/jso.24242. No abstract available.

PMID:
27206101
42.

Complications and Surveillance After Bariatric Surgery.

Concors SJ, Ecker BL, Maduka R, Furukawa A, Raper SE, Dempsey DD, Williams NN, Dumon KR.

Curr Treat Options Neurol. 2016 Jan;18(1):5. doi: 10.1007/s11940-015-0383-0.

PMID:
26860932
43.

Blood Transfusion in Major Abdominal Surgery for Malignant Tumors: A Trend Analysis Using the National Surgical Quality Improvement Program.

Ecker BL, Simmons KD, Zaheer S, Poe SL, Bartlett EK, Drebin JA, Fraker DL, Kelz RR, Roses RE, Karakousis GC.

JAMA Surg. 2016 Jun 1;151(6):518-25. doi: 10.1001/jamasurg.2015.5094.

PMID:
26763765
44.

Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis.

Ecker BL, McMillan MT, Datta J, Mamtani R, Giantonio BJ, Dempsey DT, Fraker DL, Drebin JA, Karakousis GC, Roses RE.

Cancer. 2016 Mar 1;122(5):693-701. doi: 10.1002/cncr.29840. Epub 2015 Dec 30.

45.

Laparoscopic hand-assisted versus robotic-assisted laparoscopic sleeve gastrectomy: experience of 103 consecutive cases.

Kannan U, Ecker BL, Choudhury R, Dempsey DT, Williams NN, Dumon KR.

Surg Obes Relat Dis. 2016 Jan;12(1):94-9. doi: 10.1016/j.soard.2015.07.011. Epub 2015 Jul 21.

PMID:
26507939
46.

Laparoscopic transhiatal esophagectomy improves hospital outcomes and reduces cost: a single-institution analysis of laparoscopic-assisted and open techniques.

Ecker BL, Savulionyte GE, Datta J, Dumon KR, Kucharczuk J, Williams NN, Dempsey DT.

Surg Endosc. 2016 Jun;30(6):2535-42. doi: 10.1007/s00464-015-4519-9. Epub 2015 Sep 28.

PMID:
26416370
47.

Minimally invasive gastrectomy for gastric adenocarcinoma in the United States: Utilization and short-term oncologic outcomes.

Ecker BL, Datta J, McMillan MT, Poe SL, Drebin JA, Fraker DL, Dempsey DT, Karakousis GC, Roses RE.

J Surg Oncol. 2015 Nov;112(6):616-21. doi: 10.1002/jso.24052. Epub 2015 Sep 23.

PMID:
26394810
48.

Resident education in robotic-assisted vertical sleeve gastrectomy: outcomes and cost-analysis of 411 consecutive cases.

Ecker BL, Maduka R, Ramdon A, Dempsey DT, Dumon KR, Williams NN.

Surg Obes Relat Dis. 2016 Feb;12(2):313-20. doi: 10.1016/j.soard.2015.05.011. Epub 2015 May 27.

PMID:
26363712
49.

Lymph node identification following neoadjuvant therapy in rectal cancer: A stage-stratified analysis using the surveillance, epidemiology, and end results (SEER)-medicare database.

Ecker BL, Paulson EC, Datta J, Jeganathan AN, Aarons C, Kelz RR, Mahmoud NN.

J Surg Oncol. 2015 Sep;112(4):415-20. doi: 10.1002/jso.23991. Epub 2015 Aug 6.

PMID:
26250884
50.

Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.

Datta J, McMillan MT, Ecker BL, Karakousis GC, Mamtani R, Plastaras JP, Giantonio BJ, Drebin JA, Dempsey DT, Fraker DL, Roses RE.

Ann Surg. 2016 Feb;263(2):298-305. doi: 10.1097/SLA.0000000000001360.

PMID:
26135687

Supplemental Content

Loading ...
Support Center